Research programme: needle-free injectables - Glide

Drug Profile

Research programme: needle-free injectables - Glide

Alternative Names: Exenatide SDI®; Glide teriparatide; Teriparatide SDI®

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Glide Technologies
  • Class Peptide hormones
  • Mechanism of Action Glucagon-like peptide 1 stimulants; Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Type 2 diabetes mellitus
  • No development reported Osteoporosis

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in United Kingdom (SC, Needle-free injection)
  • 06 Jan 2016 Preclinical trials in Type-2 diabetes mellitus in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top